Extending half-life in coagulation factors: where do we stand?
- 31 December 2008
- journal article
- review article
- Published by Elsevier in Thrombosis Research
- Vol. 122, S2-S8
- https://doi.org/10.1016/s0049-3848(08)70027-6
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The tertiary structure and domain organization of coagulation factor VIIIBlood, 2008
- Prolonged in-vivo half-life of factor VIIa by fusion to albuminThrombosis and Haemostasis, 2008
- Clearance of von Willebrand factorThrombosis and Haemostasis, 2008
- Enhanced Circulating Half-Life and Antitumor Activity of a Site-Specific Pegylated Interferon-α Protein TherapeuticBioconjugate Chemistry, 2007
- Clearance mechanisms of von Willebrand factor and factor VIIIJournal of Thrombosis and Haemostasis, 2007
- Prolonged bleeding-free period following prophylactic infusion of recombinant factor VIII reconstituted with pegylated liposomesBlood, 2006
- Factor VIII efficient and specific non-covalent binding to PEGylated liposomes enables prolongation of its circulation time and haemostatic efficacyThrombosis and Haemostasis, 2005
- Peptide and protein PEGylationBiomaterials, 2001
- Prolonged Half-Life in the Circulation of a Chemical Conjugate Between a Pro-Urokinase Derivative and Human Serum AlbuminEuropean Journal of Biochemistry, 1995
- Structure of human factor VIIINature, 1984